Skip to main content

SYSTEMATIC REVIEW article

Front. Cardiovasc. Med.

Sec. Sex and Gender in Cardiovascular Medicine

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1502985

This article is part of the Research Topic Sex-Specific Risk Factors and Cardiovascular Disease Risk in Women View all 9 articles

Exploring associations between estrogen and gene candidates identified by coronary artery disease genome-wide association studies

Provisionally accepted
Ava Parissa Aminbakhsh Ava Parissa Aminbakhsh 1Emilie T Théberge Emilie T Théberge 1Ellizabeth Burden Ellizabeth Burden 1,2Cindy Kalenga Adejumo Cindy Kalenga Adejumo 1,2Annabel Katherine Gravely Annabel Katherine Gravely 1Anna Lehman Anna Lehman 1,2Tara Sedlak Tara Sedlak 1,2*
  • 1 University of British Columbia, Vancouver, Canada
  • 2 Vancouver Coastal Health, Vancouver, British Columbia, Canada

The final, formatted version of the article will be published soon.

    Introduction: Coronary artery disease (CAD) is the leading cause of death around the world, with epidemiological sex and gender differences in prevalence, pathophysiology and outcomes. It has been hypothesized that sex steroids, like estrogen, may contribute to these sex differences. There is a relatively large genetic component to developing CAD, with heritability estimates ranging between 40-60%. In the last two decades, genome-wide association studies (GWAS) have contributed substantially to advancing the understanding of genetic candidates contributing to CAD. The aim of this study was to determine if genes discovered in CAD GWASs are affected by estrogen via direct modulation or indirect down-stream targets.Methods: A scoping review was conducted using MEDLINE and EMBASE for studies of atherosclerotic coronary artery disease and a genome-wide association study (GWAS) design. Analysis was limited to candidate genes with corresponding single nucleotide polymorphisms (SNPs) surpassing genome-wide significance and had been mapped to genes by study authors. The number of studies that conducted sex-stratified analyses with significant genes were quantified. A literature search of the final gene lists was done to examine any evidence suggesting estrogen may modulate the genes and/or gene products.Results: There were 60 eligible CAD GWASs meeting inclusion criteria for data extraction. Of these 60, only 36 had genome-wide significant SNPs reported, and only 3 of these had significant SNPs from sex-stratified analyses mapped to genes. From these 36 studies, a total of 61 genes were curated, of which 26 genes (43%) were found to have modulation by estrogen. All 26 were discovered in studies that adjusted for sex.

    Keywords: Coronary Artery Disease, genome wide association study, estrogen, Gene candidates, sex differences

    Received: 27 Sep 2024; Accepted: 04 Mar 2025.

    Copyright: © 2025 Aminbakhsh, Théberge, Burden, Kalenga Adejumo, Gravely, Lehman and Sedlak. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Tara Sedlak, University of British Columbia, Vancouver, Canada

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more